Movement Neuroscience Program, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, 60 Musk Avenue, Kelvin Grove, QLD 4059, Australia ; School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, 60 Musk Avenue, Kelvin Grove, QLD 4059, Australia ; Department of Neurology, Shandong Provincial Hospital, Jinan, Shandong 250021, China.
Movement Neuroscience Program, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, 60 Musk Avenue, Kelvin Grove, QLD 4059, Australia ; School of Exercise Science, Australian Catholic University, Brisbane, QLD 4014, Australia.
Parkinsons Dis. 2014;2014:684758. doi: 10.1155/2014/684758. Epub 2014 Jul 17.
The specific aspects of cognition contributing to balance and gait have not been clarified in people with Parkinson's disease (PD). Twenty PD participants and twenty age- and gender-matched healthy controls were assessed on cognition and clinical mobility tests. General cognition was assessed with the Mini Mental State Exam and Addenbrooke's Cognitive Exam. Executive function was evaluated using the Trail Making Tests (TMT-A and TMT-B) and a computerized cognitive battery which included a series of choice reaction time (CRT) tests. Clinical gait and balance measures included the Tinetti, Timed Up & Go, Berg Balance, and Functional Reach tests. PD participants performed significantly worse than the controls on the tests of cognitive and executive function, balance, and gait. PD participants took longer on Trail Making Tests, CRT-Location, and CRT-Colour (inhibition response). Furthermore, executive function, particularly longer times on CRT-Distracter and greater errors on the TMT-B, was associated with worse balance and gait performance in the PD group. Measures of general cognition were not associated with balance and gait measures in either group. For PD participants, attention and executive function were impaired. Components of executive function, particularly those involving inhibition response and distracters, were associated with poorer balance and gait performance in PD.
在帕金森病(PD)患者中,尚未明确与平衡和步态相关的认知特定方面。20 名 PD 参与者和 20 名年龄和性别匹配的健康对照者接受了认知和临床移动性测试评估。一般认知能力采用 Mini Mental State Exam 和 Addenbrooke's Cognitive Exam 进行评估。使用 Trail Making Tests (TMT-A 和 TMT-B) 和一系列选择反应时 (CRT) 测试评估执行功能。临床步态和平衡测量包括 Tinetti、Timed Up & Go、Berg Balance 和功能性伸展测试。PD 参与者在认知和执行功能、平衡和步态测试中的表现明显差于对照组。PD 参与者在 Trail Making Tests、CRT-Location 和 CRT-Colour(抑制反应)上花费的时间更长。此外,在 PD 组中,执行功能,特别是 CRT-Distracter 上花费的时间更长,以及 TMT-B 上的错误更多,与更差的平衡和步态表现相关。在两组中,一般认知测量都与平衡和步态测量无关。对于 PD 参与者,注意力和执行功能受损。执行功能的组成部分,特别是涉及抑制反应和干扰因素的部分,与 PD 中更差的平衡和步态表现相关。